We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The latest suit alleges that Mallinckrodt and Questcor—a company that Mallinckrodt acquired in 2014—used a charitable foundation to support “free” prescriptions for its HP Acthar gel. Read More
Acting Commissioner Ned Sharpless said that the agency will continue to take action against clinics or manufacturers that promote products “ in ways that make them drugs under the law.” Read More
The agency said “there isn’t enough evidence to support the use of stem cells for purposes other than reconstitution of blood formation and the immune system.” Read More